Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy
Peter J. Taylor(Prince of Wales Hospital), Michael F. Buckley(Prince of Wales Hospital), Glenda Mullan(Prince of Wales Hospital), Sarah Maroulis(Prince of Wales Hospital), Robyn L. Pedersen(Sydney Children's Hospital), George Elakis(New South Wales Department of Health), Christopher G. Bell(Queen Mary University of London), A. Baumli(Prince of Wales Hospital), B. Prosper-Gutierrez(Prince of Wales Hospital), F. De La Puente-Alonso(Prince of Wales Hospital), David Mowat(UNSW Sydney)
Cited by 51
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
DNA methylation aging clocks: challenges and recommendations
|Genome biology|2019|1.1k